Learn Why Targeted Lytic Peptides Are a Promising Treatment for Multiple Cancer Types

Interested in learning more about the A28 targeted lytic peptide platform? We would be pleased to have an opportunity to share our compelling story, platform, pipeline, and data with you.

Contact Us